LIGAND PHARMACEUTICALS INC — 425 Filings
47 425 filings on record
This page lists all 425 filings submitted to the SEC by LIGAND PHARMACEUTICALS INC (LGNZZ), sorted by most recent first. Each row links to the full filing on EdgarLookup. LIGAND PHARMACEUTICALS INC has filed 47 425 documents with the SEC since 2014. To view all SEC filings by LIGAND PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
15-12G
3
3/A
4
4/A
424B1
424B3
424B5
425
5
8-A12B
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DEFN14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREM14A
PREN14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 425 | 425 | 0001193125-22-256264 | Oct 3, 2022 | — |
| 425 | 425 | 0001104659-22-094075 | Aug 24, 2022 | — |
| 425 | 425 | 0001104659-22-072720 | Jun 21, 2022 | — |
| 425 | 425 | 0000886163-22-000045 | May 5, 2022 | — |
| 425 | 425 | 0001193125-22-083451 | Mar 24, 2022 | — |
| 425 | 425 | 0001193125-22-082897 | Mar 23, 2022 | — |
| 425 | FORM 8-K | 0001193125-10-003428 | Jan 8, 2010 | — |
| 425 | RULE 425 | 0001193125-09-256662 | Dec 21, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-254656 | Dec 17, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-253136 | Dec 15, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-241169 | Nov 24, 2009 | — |
| 425 | 425 | 0001193125-09-239917 | Nov 23, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-238400 | Nov 19, 2009 | — |
| 425 | 425 | 0001193125-09-229878 | Nov 10, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-227463 | Nov 6, 2009 | — |
| 425 | RULE 425 | 0001193125-09-227486 | Nov 6, 2009 | — |
| 425 | 425 | 0001157523-09-007788 | Nov 5, 2009 | — |
| 425 | FORM 425 | 0001193125-09-225178 | Nov 5, 2009 | — |
| 425 | FORM 425 | 0001193125-09-220067 | Nov 2, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-215911 | Oct 28, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-189569 | Sep 10, 2009 | — |
| 425 | FORM 425 | 0001193125-09-189065 | Sep 9, 2009 | — |
| 425 | FORM 425 | 0001193125-09-184801 | Aug 31, 2009 | — |
| 425 | FORM 425 | 0001193125-09-182106 | Aug 26, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-180486 | Aug 24, 2009 | — |
| 425 | FORM 425 | 0001193125-08-233880 | Nov 12, 2008 | — |
| 425 | 425 | 0001104659-08-069897 | Nov 12, 2008 | — |
| 425 | 425 | 0001104659-08-069203 | Nov 7, 2008 | — |
| 425 | FORM 425 | 0001193125-08-228447 | Nov 7, 2008 | — |
| 425 | FORM 425 | 0001193125-08-228133 | Nov 6, 2008 | — |
| 425 | 425 | 0001104659-08-068646 | Nov 6, 2008 | — |
| 425 | 425 | 0001193125-08-224387 | Nov 4, 2008 | — |
| 425 | 425 | 0001104659-08-067786 | Nov 4, 2008 | — |
| 425 | FORM 425 | 0001193125-08-223007 | Nov 3, 2008 | — |
| 425 | 425 | 0001104659-08-067443 | Nov 3, 2008 | — |
| 425 | FORM 425 | 0001193125-08-218054 | Oct 28, 2008 | — |
| 425 | 425 | 0001104659-08-066290 | Oct 28, 2008 | — |
| 425 | 425 | 0001104659-08-064078 | Oct 14, 2008 | — |
| 425 | FORM 8-K | 0001193125-08-210195 | Oct 14, 2008 | — |
| 425 | 425 | 0001104659-08-061786 | Oct 3, 2008 | — |
| 425 | 425 | 0001104659-08-060500 | Sep 26, 2008 | — |
| 425 | FORM 8-K | 0001193125-08-202170 | Sep 26, 2008 | — |
| 425 | RULE 425 | 0001193125-08-201211 | Sep 25, 2008 | — |
| 425 | AMENDMENT NO.1 TO FORM 8-K | 0001193125-08-200786 | Sep 25, 2008 | — |
| 425 | 8-K | 0001104659-08-060463 | Sep 25, 2008 | — |
| 425 | 8-K | 0001104659-08-060459 | Sep 25, 2008 | — |
| 425 | LIGAND PHARMACEUTICALS INC. 8-K | 0001157523-08-007615 | Sep 24, 2008 | — |